Security Snapshot

Petco Health & Wellness Company, Inc. - COM (WOOF) Institutional Ownership

CUSIP: 71601V105

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

201

Shares (Excl. Options)

297,849,565

Price

$2.78

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / COM
Symbol
WOOF on Nasdaq
Price per share
$2.80
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
297,849,565
Total reported value
$827,732,692
% of total 13F portfolios
0%
Share change
+1,925,871
Value change
+$5,137,266
Number of holders
201
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • WOOF - Petco Health & Wellness Company, Inc. - COM is tracked under CUSIP 71601V105.
  • 201 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 210 to 201 between Q4 2025 and Q1 2026.
  • Reported value moved from $836,819,470 to $827,732,692.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 201 institutions filings for Q1 2026.

Open SEC Evidence

Security key

71601V105

Latest holder period

Q1 2026

13F holders

201

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 201 institutional investors reported holding 297,849,565 shares of Petco Health & Wellness Company, Inc. - COM (WOOF).

Institutional Holders of Petco Health & Wellness Company, Inc. - COM (WOOF) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 297,849,565 $827,732,692 +$5,137,266 $2.78 201
2025 Q4 297,798,015 $836,819,470 -$5,532,992 $2.81 210
2025 Q3 298,199,337 $1,153,491,754 -$21,139,585 $3.87 204
2025 Q2 305,255,937 $864,041,238 -$1,443,022 $2.83 196
2025 Q1 305,323,880 $930,804,462 -$15,936,025 $3.05 200
2024 Q4 308,390,897 $1,175,012,560 +$19,995,049 $3.81 205
2024 Q3 300,542,484 $1,367,434,166 +$585,435 $4.55 172
2024 Q2 302,537,021 $1,141,292,857 +$37,945,128 $3.78 176
2024 Q1 297,590,971 $678,191,754 -$4,901,809 $2.28 161
2023 Q4 297,253,101 $939,335,188 -$4,816,891 $3.16 186
2023 Q3 148,350,056 $603,641,914 -$67,946,835 $4.09 183
2023 Q2 148,074,303 $1,317,253,697 +$49,908,254 $8.90 181
2023 Q1 142,831,134 $1,285,350,829 -$11,994,930 $9.00 190
2022 Q4 144,717,816 $1,372,489,082 -$43,770,189 $9.48 200
2022 Q3 148,021,143 $1,651,780,766 -$195,387,520 $11.16 188
2022 Q2 157,652,871 $2,323,960,751 +$93,080,549 $14.74 204
2022 Q1 149,764,948 $2,930,940,847 +$138,338,826 $19.57 201
2021 Q4 142,254,609 $2,814,929,457 -$146,425,655 $19.79 210
2021 Q3 142,075,888 $2,997,865,769 +$48,170,604 $21.10 181
2021 Q2 139,778,404 $3,132,443,018 +$324,377,275 $22.41 177
2021 Q1 125,287,556 $2,776,353,826 +$2,776,129,705 $22.16 136
2020 Q4 272 $5,000 +$1,000 $16.55 2
2020 Q3 180 $4,000 $22.22 1
2020 Q2 180 $4,000 $22.22 1
2020 Q1 180 $4,000 $22.22 1
2019 Q4 180 $4,000 $22.22 1
2019 Q3 180 $4,000 $22.22 1
2019 Q2 180 $4,000 $22.22 1
2019 Q1 180 $4,000 $22.22 1
2016 Q3 0 $0 -$10,000 $2.80 0
2016 Q2 500 $10,000 $20.00 1
2016 Q1 500 $10,000 $20.00 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .